Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bolt Biotherapeutics Inc (NQ: BOLT ) 0.5655 -0.0569 (-9.14%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 377,476 Open 0.6224 Bid (Size) 0.5825 (3) Ask (Size) 0.5849 (15) Prev. Close 0.6224 Today's Range 0.5610 - 0.6224 52wk Range 0.5450 - 1.560 Shares Outstanding 8,709,974 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update November 12, 2024 From Bolt Biotherapeutics, Inc. Via GlobeNewswire Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting November 07, 2024 From Bolt Biotherapeutics, Inc. Via GlobeNewswire Performance YTD -51.25% -51.25% 1 Month -11.36% -11.36% 3 Month -18.16% -18.16% 6 Month -28.42% -28.42% 1 Year -40.16% -40.16% More News Read More Bolt Biotherapeutics Announces Changes to its Board of Directors September 04, 2024 From Bolt Biotherapeutics, Inc. Via GlobeNewswire BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm September 03, 2024 From The Schall Law Firm Via Business Wire BOLT Deadline: Rosen Law Firm Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights September 02, 2024 From Rosen Law Firm Via Business Wire BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm September 02, 2024 From Schall Law Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm August 30, 2024 From Bragar Eagel & Squire Via GlobeNewswire DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt August 29, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire Bolt Biotherapeutics to Participate in Upcoming September Conferences August 28, 2024 From Bolt Biotherapeutics, Inc. Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm August 26, 2024 From Bragar Eagel & Squire Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, FutureFuel, SeaStar, and Bolt and Encourages Investors to Contact the Firm August 20, 2024 From Bragar Eagel & Squire Via GlobeNewswire BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm August 20, 2024 From Schall Law Via GlobeNewswire ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLT August 17, 2024 From The Rosen Law Firm PA Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NIKE, FutureFuel, SeaStar, and Bolt and Encourages Investors to Contact the Firm August 16, 2024 From Bragar Eagel & Squire Via GlobeNewswire BOLT Stock Earnings: Bolt Biotherapeutics Misses EPS, Beats Revenue for Q2 2024 August 13, 2024 Via InvestorPlace Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update August 13, 2024 From Bolt Biotherapeutics, Inc. Via GlobeNewswire BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm August 13, 2024 From Schall Law Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NIKE, FutureFuel, SeaStar, and Bolt and Encourages Investors to Contact the Firm August 12, 2024 From Bragar Eagel & Squire Via GlobeNewswire ROSEN, A LONGSTANDING LAW FIRM, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLT August 09, 2024 From The Rosen Law Firm PA Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm August 06, 2024 From Bragar Eagel & Squire Via GlobeNewswire BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm August 06, 2024 From Schall Law Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, American Airlines, and Bolt and Encourages Investors to Contact the Firm August 02, 2024 From Bragar Eagel & Squire Via GlobeNewswire BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm July 31, 2024 From Schall Law Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm July 30, 2024 From Bragar Eagel & Squire Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NIKE, FutureFuel, SeaStar, and Bolt and Encourages Investors to Contact the Firm July 26, 2024 From Bragar Eagel & Squire Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
